The course of Covid 19 in Inflammatory Bowel Disease: protective role of TNF antagonists Response to: Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
Source: Gastroenterology - Category: Gastroenterology Authors: Maria Cappello, Anita Busacca, Laura Guida Source Type: research